Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial
about
Sumatriptan (oral route of administration) for acute migraine attacks in adultsSelf-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische KopfschmerzgesellschAcetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial--a commentA comment on acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialAcetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled studyProinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classNetwork meta-analysis of migraine disorder treatment by NSAIDs and triptans.Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?New drugs for migraineComparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study.Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach.Patterns of triptans use: a study based on the records of a community pharmaceutical department.Results from a pharmacy-based patient survey on the use of a fixed combination analgesic containing acetylsalicylic acid, paracetamol and caffeine by self-diagnosing and self-treating patientsThe pharmacological management of migraine, part 1: overview and abortive therapy.Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review.Are the current IHS guidelines for migraine drug trials being followed?Symptomatic Overlap and Therapeutic Opportunities in Primary Headache.Drug safety in acute migraine treatment.Comparative tolerability of treatments for acute migraine: A network meta-analysis.Diet and Headache: Part 1.Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.Patient preference for triptan formulations: a prospective study with zolmitriptan.Comments on 'Efficacy of fixed combinations of acetylsalicylic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review'.Triptans: low utilization and high turnover in the general population.Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
P2860
Q24203707-E14E33FF-43D2-4CB8-B470-EEB32067B66EQ24619383-8E97A452-2A52-4B87-9033-B4CDED1D1CF7Q28195314-2015530C-2CFE-4334-AFB6-19F553F385F4Q28195316-F7D0B2AC-270F-41AB-BEF9-DA5F40ABDFE3Q28196594-C3636757-1B04-46C5-8E1D-FE56D20AF42BQ28292548-6EDEA4BC-599A-45BD-94F8-C197365AF040Q30831647-2F0E9DB1-3614-4FB1-988E-58BD26CA8FD0Q33859031-D234E21B-D408-470F-8411-0899AB01ED18Q36332611-C0C8A4CA-EE6D-46D2-97F8-733098C945B5Q36357113-AC32FA94-EAA5-494A-ADCA-3FF074697DCFQ36419543-1EFA6277-5FCD-4A91-93D3-481130FA4B91Q36903088-975E6358-A23E-4E61-8AF6-B55D9BF6484EQ37004760-FC20E805-C2F4-4C87-9728-0E71A1395132Q37340160-4FA4601A-8AB1-44F6-89E0-66EEB67CA581Q37675003-97E0D019-EE9E-461C-926E-60EDA3EDDAFEQ37798757-0C8C6C33-3D5A-4AD9-BFAE-8457757DAF24Q38238909-8F860FF6-173F-4DD9-BBE5-90E6168BC411Q38378898-1DD7A1DD-F1F5-4919-835C-131193D3B0D4Q38927015-96772BC4-A3E1-4D03-8427-E58539E8DD75Q38971680-5278CB7F-E9B8-408E-A68F-FBD86E452F1CQ39316816-45381CD0-807C-44DB-86D3-71ED54373B68Q42632079-DAE4C100-F30F-4090-A4F3-E055CDE88A5CQ42970739-5358E5A0-12BF-4F28-9891-F41862313B4DQ43280720-9C2348FB-EFBA-4FF2-9F17-68BFF21C5B59Q50758391-0F8AFFAB-F0B3-4BAB-9A0D-41D7281EE392
P2860
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial
description
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
scientific article (publication date: September 2005)
@en
vedecký článok (publikovaný 2005-09)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd in 2005-09)
@nl
наукова стаття, опублікована у вересні 2005
@uk
مقالة علمية (نشرت في سبتمبر 2005)
@ar
name
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@ast
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@en
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@nl
type
label
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@ast
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@en
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@nl
prefLabel
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@ast
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@en
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@nl
P2093
P2860
P921
P3181
P1433
P1476
Acetaminophen, aspirin, and ca ...... : results from the ASSET trial
@en
P2093
Arthur H Elkind
Howard Hoffman
Jean-Pierre Battikha
Jeffrey Baggish
Jerome Goldstein
Joel R Saper
R Michael Gallagher
Timothy R Smith
P2860
P304
P3181
P356
10.1111/J.1526-4610.2005.05177.X
P407
P577
2005-09-01T00:00:00Z